<p>Roche drug Hemlibra has a good chance to become the first choice of treatment for the patients who are suffering from Hemopilia.Basically, Hemlibra is a humanized monoclonal antibody drug for the treatment of haemophilia which is given through an injection, it was observed that it reduces the bleed dramatically in hemphilia tests. </p><p>At the world Federation of Hemophilia&rsquo;s world congress in Scotland,Roche&rsquo;s-Genentech unit disclosed the details from the twophases 3 studies on emicizumab. The trails were termed as HEAVEN-3 &amp; HEAVEN-4. </p><blockquote><p> At the world Federation of Hemophilia&rsquo;s world congress in Scotland,Roche&rsquo;s-Genentech unit disclosed the details from the twophases 3 studies on emicizumab. The trails were termed as HEAVEN-3 &amp; HEAVEN-4..</p></blockquote><p>It was reported that Hemlibra was able to cut down 96% of the bleeds in Hemophilia. Some comparisons were observed between a patient who didn&rsquo;t received preventive treatment whereas a patient who received the preventive treatment in the form of clotting factors it reduces them by 68%.</p><p>The firm will submit the new data to regulators in the U.S. and Europe for approval. </p>